產(chǎn)品詳情
簡單介紹：
Anti-RNF210抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-RNF210抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-RNF210
Cat. Number:
Anti-RNF210抗體KL-8494R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
RFPL4A is a 287 amino acid protein. RFPL4A contains a cysteine-rich RING finger-like region (C3YC4), a coiled-coil motif, and B30.2 domains characteristic of the RING-B30 family of E3 ubiquitin-protein ligases, such as MID1. The RFPL4A gene maps to human chromosome 19q13.42. Chromosome 19 consists of Anti-RNF210抗體approximately 63 million bases and makes up over 2% of human genomic DNA. Chromosome 19 includes a diversity of interesting genes and is recognized for having the greatest gene density of the human chromosomes. It is the genetic home for a number of immunoglobulin superfamily members including the killer cell and leukocyte Ig-like receptors, a number of ICAMs, the CEACAM and PSG families, and Fc?receptors. Key genes for eye color and hair color also map to chromosome 19. Peutz-Jeghers syndrome, spinocerebellar ataxia type 6, the stroke disorder CADASIL, hypercholesterolemia and insulin-dependent diabetes have been linked to chromosome 19.
Also known as:
RNF210; Ret finger protein like 4; Anti-RNF210抗體Ret finger protein-like 4A; RFPL4; RFPL4A; RFPLA_HUMAN; RING finger protein 210.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Pig, Horse, .
●
Immunogen: KLH conjugated syntheticAnti-RNF210抗體peptide derived from human RFPL4A/RNF210.
●
Predicted Molecular Weight: 32kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications. Anti-RNF210抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-RNF210抗體
Optimal working dilutions must be determined by the end user.
